Avanos medical, inc. announces third quarter 2019 results, completes acquisition of endoclear llc

Avanos medical, inc. announces third quarter 2019 results, completes acquisition of endoclear llc.q3 adjusted earnings per share $0.30 from continuing operations.q3 loss per share $0.24.q3 sales $171 million versus refinitiv ibes estimate of $179.8 million.q3 earnings per share estimate $0.31 -- refinitiv ibes data.revised its full-year 2019 outlook for net sales growth, in constant currency, from 8 to 10 percent to 5 to 7 percent.revised its full-year 2019 outlook for adjusted diluted earnings per share from $1.15 to $1.25 to $1.00 to $1.10.fy2019 earnings per share view $1.19, revenue view $708.5 million -- refinitiv ibes data.
AVNS Ratings Summary
AVNS Quant Ranking